TY - JOUR AU - Chung, V. AU - Liu, L. AU - Bian, Z. AU - Zhao, Z. AU - Leuk Fong, W. AU - Kum, W. F. AU - Gao, J. AU - Li, M. PY - 2006 DA - 2006// TI - Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review JO - Mov Disord VL - 21 UR - https://doi.org/10.1002/mds.21008 DO - 10.1002/mds.21008 ID - Chung2006 ER - TY - JOUR AU - Santens, P. AU - Boon, P. AU - Van Roost, D. AU - Caenaert, J. PY - 2003 DA - 2003// TI - The pathophysiology of motor symptoms in Parkinson’s disease JO - Acta Neurol Belg VL - 103 ID - Santens2003 ER - TY - JOUR AU - Obeso, J. A. AU - Rodriguez-Oroz, M. C. AU - Rodriguez, M. AU - Lanciego, J. L. AU - Artieda, J. AU - Gonzalo, N. AU - Olanow, C. W. PY - 2000 DA - 2000// TI - Pathophysiology of the basal ganglia in Parkinson's disease JO - Trends Neurosci VL - 23 UR - https://doi.org/10.1016/S1471-1931(00)00028-8 DO - 10.1016/S1471-1931(00)00028-8 ID - Obeso2000 ER - TY - JOUR AU - Fahn, S. AU - Oakes, D. AU - Shoulson, I. PY - 2004 DA - 2004// TI - Levodopa and the progression of Parkinson’s disease JO - N Engl J Med. VL - 351 UR - https://doi.org/10.1056/NEJMoa033447 DO - 10.1056/NEJMoa033447 ID - Fahn2004 ER - TY - JOUR AU - Park, A. AU - Stacy, M. PY - 2009 DA - 2009// TI - Non-motor symptoms in Parkinson's disease JO - J Neurol VL - 56 UR - https://doi.org/10.1007/s00415-009-5240-1 DO - 10.1007/s00415-009-5240-1 ID - Park2009 ER - TY - STD TI - Songhee Jeon, Seong-Uk Park, Byung-Soo Koo, Hongwon Kim, Soonbong Baek, Sora Ahn, Ahreum Lee, Jeawan Jang, Hye Hyun Yoo, Ji-Yeun Park, Yanghwa Kang, Jongpil Kim, Hi-Joon Park, Therapeutic effect of herbal formulation (KD5040): effect on cell death and motor function in Parkinson’s disease. Chin J Integr Med. In press. ID - ref6 ER - TY - JOUR AU - Rozas, G. AU - Lopez-Martin, E. AU - Guerra, M. J. AU - Labandeira-Garcia, J. L. PY - 1998 DA - 1998// TI - The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism JO - J Neurosci Methods VL - 83 UR - https://doi.org/10.1016/S0165-0270(98)00078-8 DO - 10.1016/S0165-0270(98)00078-8 ID - Rozas1998 ER - TY - JOUR AU - Ookubo, M. AU - Yokoyama, H. AU - Takagi, S. AU - Kato, H. AU - Araki, T. PY - 2008 DA - 2008// TI - Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice JO - Mol Cell Endocrinol VL - 296 UR - https://doi.org/10.1016/j.mce.2008.07.019 DO - 10.1016/j.mce.2008.07.019 ID - Ookubo2008 ER - TY - JOUR AU - Ding, Y. M. AU - Restrepo, J. AU - Won, L. AU - Hwang, D. Y. AU - Kim, K. S. AU - Kang, U. J. PY - 2007 DA - 2007// TI - Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease JO - Neurobiol Dis VL - 27 UR - https://doi.org/10.1016/j.nbd.2007.03.013 DO - 10.1016/j.nbd.2007.03.013 ID - Ding2007 ER - TY - JOUR AU - Lundblad, M. AU - Picconi, B. AU - Lindgren, H. AU - Cenci, M. A. PY - 2004 DA - 2004// TI - A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function JO - Neurobiol Dis VL - 16 UR - https://doi.org/10.1016/j.nbd.2004.01.007 DO - 10.1016/j.nbd.2004.01.007 ID - Lundblad2004 ER - TY - JOUR AU - Eckstein, J. A. AU - Ammerman, G. M. AU - Reveles, J. M. AU - Ackermann, B. L. PY - 2008 DA - 2008// TI - Analysis of glutamine, glutamate, pyroglutamate, and GABA in cerebrospinal fluid using ion pairing HPLC with positive electrospray LC/MS/MS JO - J Neurosci Methods VL - 171 UR - https://doi.org/10.1016/j.jneumeth.2008.02.019 DO - 10.1016/j.jneumeth.2008.02.019 ID - Eckstein2008 ER - TY - JOUR AU - Cedarbaum, J. M. AU - Gandy, S. E. AU - Mcdowell, F. H. PY - 1991 DA - 1991// TI - Early initiation of Levodopa treatment does not promote the development of motor response fluctuations, Dyskinesias, or dementia in Parkinsons-disease JO - Neurology VL - 41 UR - https://doi.org/10.1212/WNL.41.5.622 DO - 10.1212/WNL.41.5.622 ID - Cedarbaum1991 ER - TY - JOUR AU - Kurlan, R. PY - 2005 DA - 2005// TI - "Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease JO - Neurology VL - 64 UR - https://doi.org/10.1212/01.WNL.0000152880.77812.5B DO - 10.1212/01.WNL.0000152880.77812.5B ID - Kurlan2005 ER - TY - JOUR AU - Feger, J. AU - Crossman, A. R. PY - 1984 DA - 1984// TI - Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study JO - Neurosci Lett VL - 49 UR - https://doi.org/10.1016/0304-3940(84)90127-7 DO - 10.1016/0304-3940(84)90127-7 ID - Feger1984 ER - TY - JOUR AU - Gerfen, C. R. AU - Keefe, K. A. AU - Steiner, H. PY - 1998 DA - 1998// TI - Dopamine-mediated gene regulation in the striatum JO - Adv Pharmacol VL - 42 UR - https://doi.org/10.1016/S1054-3589(08)60837-6 DO - 10.1016/S1054-3589(08)60837-6 ID - Gerfen1998 ER - TY - JOUR AU - Goldman-Rakic, P. S. AU - Selemon, L. D. PY - 1990 DA - 1990// TI - New frontiers in basal ganglia research. Introduction JO - Trends Neurosci. VL - 13 UR - https://doi.org/10.1016/0166-2236(90)90103-H DO - 10.1016/0166-2236(90)90103-H ID - Goldman-Rakic1990 ER - TY - JOUR AU - Bido, S. AU - Marti, M. AU - Morari, M. PY - 2011 DA - 2011// TI - Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels JO - J Neurochem VL - 118 UR - https://doi.org/10.1111/j.1471-4159.2011.07376.x DO - 10.1111/j.1471-4159.2011.07376.x ID - Bido2011 ER - TY - JOUR AU - Leentjens, A. F. G. PY - 2011 DA - 2011// TI - The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease a systematic review JO - Drugs VL - 71 UR - https://doi.org/10.2165/11585380-000000000-00000 DO - 10.2165/11585380-000000000-00000 ID - Leentjens2011 ER - TY - JOUR AU - Blandini, F. AU - Nappi, G. AU - Tassorelli, C. AU - Martignoni, E. PY - 2000 DA - 2000// TI - Functional changes of the basal ganglia circuitry in Parkinson's disease JO - Prog Neurobiol VL - 62 UR - https://doi.org/10.1016/S0301-0082(99)00067-2 DO - 10.1016/S0301-0082(99)00067-2 ID - Blandini2000 ER - TY - JOUR AU - Pelled, G. AU - Bergman, H. AU - Goelman, G. PY - 2002 DA - 2002// TI - Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study JO - Eur J Neurosci VL - 15 UR - https://doi.org/10.1046/j.0953-816x.2001.01866.x DO - 10.1046/j.0953-816x.2001.01866.x ID - Pelled2002 ER - TY - JOUR AU - Calabresi, P. AU - Di Filippo, M. AU - Ghiglieri, V. AU - Tambasco, N. AU - Picconi, B. PY - 2010 DA - 2010// TI - Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(10)70218-0 DO - 10.1016/S1474-4422(10)70218-0 ID - Calabresi2010 ER - TY - JOUR AU - Fan, X. T. AU - Zhao, F. AU - Ai, Y. AU - Andersen, A. AU - Hardy, P. AU - Ling, F. AU - Gerhardt, G. A. AU - Zhang, Z. AU - Quintero, J. E. PY - 2014 DA - 2014// TI - Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency JO - Brain Res VL - 1552 UR - https://doi.org/10.1016/j.brainres.2013.12.035 DO - 10.1016/j.brainres.2013.12.035 ID - Fan2014 ER - TY - JOUR AU - Jenner, P. PY - 2004 DA - 2004// TI - Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation JO - Neurology VL - 62 UR - https://doi.org/10.1212/WNL.62.1_suppl_1.S47 DO - 10.1212/WNL.62.1_suppl_1.S47 ID - Jenner2004 ER - TY - JOUR AU - Bordet, R. AU - Ridray, S. AU - Schwartz, J. C. AU - Sokoloff, P. PY - 2000 DA - 2000// TI - Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats JO - Eur J Neurosci VL - 12 UR - https://doi.org/10.1046/j.1460-9568.2000.00089.x DO - 10.1046/j.1460-9568.2000.00089.x ID - Bordet2000 ER - TY - JOUR AU - Santini, E. AU - Valjent, E. AU - Usiello, A. AU - Carta, M. AU - Borgkvist, A. AU - Girault, J. A. AU - Herve, D. AU - Greengard, P. AU - Fisone, G. PY - 2007 DA - 2007// TI - Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia JO - J Neurosci VL - 27 UR - https://doi.org/10.1523/JNEUROSCI.0852-07.2007 DO - 10.1523/JNEUROSCI.0852-07.2007 ID - Santini2007 ER - TY - JOUR AU - Lebel, M. AU - Chagniel, L. AU - Bureau, G. AU - Cyr, M. PY - 2010 DA - 2010// TI - Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat JO - Neurobiol Dis VL - 38 UR - https://doi.org/10.1016/j.nbd.2009.12.027 DO - 10.1016/j.nbd.2009.12.027 ID - Lebel2010 ER - TY - STD TI - Bertran-Gonzalez J, Herve D, Girault JA, Valjent E. What is the degree of segregation between striatonigral and striatopallidal projections? Front Neuroanat 2010, 4: doi:10.3389/fnana.2010.00136 ID - ref27 ER - TY - JOUR AU - Santini, E. AU - Alcacer, C. AU - Cacciatore, S. AU - Heiman, M. AU - Herve’, D. AU - Greengard, P. AU - Girault, J. A. AU - Valjent, E. AU - Fisone, G. PY - 2009 DA - 2009// TI - L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice JO - J Neurochem VL - 108 UR - https://doi.org/10.1111/j.1471-4159.2008.05831.x DO - 10.1111/j.1471-4159.2008.05831.x ID - Santini2009 ER - TY - JOUR AU - Valjent, E. AU - Pascoli, V. AU - Svenningsson, P. AU - Paul, S. AU - Enslen, H. AU - Corvol, J. C. AU - Stipanovich, A. AU - Caboche, J. AU - Lombroso, P. J. AU - Nairn, A. C. AU - Greengard, P. AU - Herve, D. AU - Girault, J. A. PY - 2005 DA - 2005// TI - Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0408305102 DO - 10.1073/pnas.0408305102 ID - Valjent2005 ER - TY - JOUR AU - Thomas, G. M. AU - Huganir, R. L. PY - 2004 DA - 2004// TI - MAPK cascade signalling and synaptic plasticity JO - Nat Rev Neurosci VL - 5 UR - https://doi.org/10.1038/nrn1346 DO - 10.1038/nrn1346 ID - Thomas2004 ER - TY - STD TI - Pavón N1, Martín AB, Mendialdua A, Moratalla R. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 2006, 59(1): 64–74. ID - ref31 ER - TY - JOUR AU - Fujisawa, S. AU - Murakami, Y. PY - 2016 DA - 2016// TI - Eugenol and its role in chronic diseases JO - Adv Exp Med Biol VL - 929 UR - https://doi.org/10.1007/978-3-319-41342-6_3 DO - 10.1007/978-3-319-41342-6_3 ID - Fujisawa2016 ER - TY - JOUR AU - Mnafgui, K. AU - Hajji, R. AU - Derbali, F. AU - Gammoudi, A. AU - Khabbabi, G. AU - Ellefi, H. AU - Allouche, N. AU - Kadri, A. AU - Gharsallah, N. PY - 2016 DA - 2016// TI - Anti-inflammatory, antithrombotic and cardiac remodeling preventive effects of Eugenol in Isoproterenol-induced myocardial infarction in Wistar rat JO - Cardiovasc Toxicol VL - 16 UR - https://doi.org/10.1007/s12012-015-9343-x DO - 10.1007/s12012-015-9343-x ID - Mnafgui2016 ER - TY - JOUR AU - Prasad, S. N. AU - Bharath, M. M. AU - Muralidhara PY - 2016 DA - 2016// TI - Neurorestorative effects of eugenol, a spice bioactive: evidence in cell model and its efficacy as an intervention molecule to abrogate brain oxidative dysfunctions in the streptozotocin diabetic rat JO - Neurochem Int VL - 95 UR - https://doi.org/10.1016/j.neuint.2015.10.012 DO - 10.1016/j.neuint.2015.10.012 ID - Prasad2016 ER - TY - JOUR AU - Dubey, K. AU - Anand, B. G. AU - Shekhawat, D. S. AU - Kar, K. PY - 2017 DA - 2017// TI - Eugenol prevents amyloid formation of proteins and inhibits amyloid-induced hemolysis JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep40744 DO - 10.1038/srep40744 ID - Dubey2017 ER - TY - JOUR AU - Kim, H. U. AU - Ryu, J. Y. AU - Lee, J. O. AU - Lee, S. Y. PY - 2015 DA - 2015// TI - A systems approach to traditional oriental medicine JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3167 DO - 10.1038/nbt.3167 ID - Kim2015 ER - TY - JOUR AU - AlDakheel, A. AU - Kalia, L. V. AU - Lang, A. E. PY - 2014 DA - 2014// TI - Pathogenesis-targeted, disease-modifying therapies in Parkinson disease JO - Neurotherapeutics VL - 11 UR - https://doi.org/10.1007/s13311-013-0218-1 DO - 10.1007/s13311-013-0218-1 ID - AlDakheel2014 ER - TY - JOUR AU - Lang, A. E. AU - Melamed, E. AU - Poewe, W. AU - Rascol, O. PY - 2013 DA - 2013// TI - Trial designs used to study neuroprotective therapy in Parkinson's disease JO - Mov Disord VL - 28 UR - https://doi.org/10.1002/mds.24997 DO - 10.1002/mds.24997 ID - Lang2013 ER - TY - JOUR AU - Bernheimer, H. AU - Birkmayer, W. AU - Hornykiewicz, O. AU - Jellinger, K. AU - Seitelberger, F. PY - 1973 DA - 1973// TI - Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations JO - J Neurol Sci VL - 20 UR - https://doi.org/10.1016/0022-510X(73)90175-5 DO - 10.1016/0022-510X(73)90175-5 ID - Bernheimer1973 ER -